Evaluating the utility of the HAS-BLED bleeding-estimator tool for transurethral resection of prostate.

ABSTRACT:

Objectives

To evaluate the utility of the HAS-BLED bleeding risk-estimation tool to predict for clinically significant postoperative haematuria in patients receiving transurethral resection of prostate (TURP).

Patients and methods

A single-centre, retrospective cohort analysis of patients underwent TURP from April 2019 to December 2023 for treatment of symptomatic benign prostate hyperplasia. The primary objective was to evaluate reliability of HAS-BLED score in predicting postoperative bleeding event. A focus sub-analysis was performed on anticoagulated patient cohort. Each patient was categorised in to HASBLED low-, moderate- and high-risk group according to the preestablished estimator tool. Patients' demographics, clinical, pathological and operative details were collect

SUBMITTER: Kuo LY 

PROVIDER: S-EPMC11771491 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature